Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(22)01109-6
PubMed Identifier: 35908569
Publication URI: http://europepmc.org/abstract/MED/35908569
Type: Journal Article/Review
Volume: 400
Parent Publication: Lancet (London, England)
Issue: 10349
ISSN: 0140-6736